MedTrace Logo

Undiagnosed COPD and Asthma Population Study (UCAP)

NCT03148210 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 508

Last updated 2024-03-07

No results posted yet for this study

Summary

Previous population health studies suggest that up to 10% of Canadian adults have undiagnosed asthma or COPD- these people are currently undiagnosed and untreated, even though they may have significant respiratory symptoms. Our study will use targeted casefinding to find people with undiagnosed asthma and COPD in Canadian communities. The investigators will assess their symptoms and their health care use and number of sick days to determine the burden of undiagnosed respiratory disease in these people. The investigators will then determine whether early treatment of previously undiagnosed airflow obstruction will improve patients' health outcomes.

Conditions

Interventions

DRUG

Treatment strategy using evidence-based guidelines for asthma or COPD

The respirologist will determine the clinical extent of the patient's symptoms, activity limitation, and degree of airflow obstruction and will commence the subject on asthma or COPD medications if indicated

BEHAVIORAL

Smoking Cessation

Smoking cessation counselling by a qualified educator if currently smoking

BEHAVIORAL

Participant Education

Standardized education for asthma or COPD disease

Sponsors & Collaborators

  • Ottawa Hospital Research Institute

    lead OTHER

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
SINGLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2017-06-05
Primary Completion
2024-01-09
Completion
2024-01-09

Countries

  • Canada

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03148210 on ClinicalTrials.gov